Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

Report outlining global weaknesses in preventing deadly diseases

Significant weaknesses undermine the global community's abilities to prevent, detect early, and respond efficiently to potentially deadly species-crossing microbes, such as the pandemic H1N1 influenza virus sweeping the globe, says a new report from the Institute of Medicine and National Research Council. The report provides a detailed plan for establishing and funding a comprehensive, globally coordinated system to identify novel zoonotic disease threats as early as possible wherever they arise so appropriate measures can be taken to prevent significant numbers of human illnesses and deaths, and livestock losses.

23 Sep 2009

Automated software solution for H1N1 preparation

San Diego-based Concerro, Inc., the market leader in enterprise-wide hospital shift and emergency workforce management software, is pleased to announce the launch of PanFluAware™, an automated software solution and decision making system for H1N1 preparation and response. A free webcast demonstration will be held on Friday, September 25th at 1:00 PM eastern standard time.

23 Sep 2009

Report on species-crossing microbes and H1N1

23 Sep 2009

Noveko to provide antimicrobial face masks and respirators to Air Transat

Noveko International Inc. ("the Company") announces that its subsidiary Noveko Inc. ("Noveko") has won a first order from Air Transat, Canada's leading holiday travel airline, for some 500,000 Noveko(TM) antimicrobial face masks and respirators as well as for AZURO(TM) hand sanitizers.

23 Sep 2009

Axion Health and CHS to deliver Workforce Emergency Preparedness and Response programs

Axion HealthTM (www.axionhealth.com), a workforce health protection, emergency preparedness and response provider, today announced that it will partner with Comprehensive Health Services, Inc. (www.chsmedical.com), the industry’s largest independent provider of onsite health centers, nationwide exam programs and rapid response medical readiness teams for workforce health to deliver its ReadySetTM Program for Workforce Emergency Preparedness and Response; including the ReadySet Pandemic Program for prevention, protection and response to pandemic health threats.

23 Sep 2009

Academy of Friends announces its 2009-2010 fundraising for 11 Bay Area HIV/AIDS service organizations

Academy of Friends proudly announces its 2009-2010 fundraising for 11 Bay Area HIV/AIDS service organizations. Known for its annual Academy Awards® Night Charity Gala and monthly social events, AOF raised more than $7.5 million benefitting over 70 organizations serving more than 250,000 people over the last 30 years.

23 Sep 2009

Chan calls for additional H1N1 vaccines for poor countries during WHO Asia-Pacific regional meeting

During the WHO Asia-Pacific regional meeting Monday, WHO Director-General Margaret Chan discussed the organization's efforts to ensure that poor nations have access to H1N1 vaccines, VOA News reports (Bayron, 9/21).

23 Sep 2009

Sanofi Pasteur receives additional order H1N1 vaccine

Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced today that the company has received an additional order from the U.S. Department of Health and Human Services (HHS) to produce vaccine to help protect against the Influenza A (H1N1) 2009 virus. The new order is for the production of bulk antigen equivalent to 27.3 million doses based on 15 mcg of antigen per dose.

22 Sep 2009

Antigen to block infection by genetically-diverse strains of HIV

Scientists working to develop a vaccine for the human immunodeficiency virus (HIV) report they have created the first antigen that induces protective antibodies capable of blocking infection of human cells by genetically-diverse strains of HIV. The new antigen differs from previously-tested vaccines by virtue of its chemically-activated property that enables close sharing of electrons and produces strong covalent bonding.

22 Sep 2009

U.S. HHS orders for an additional 29 million doses of MedImmune's influenza vaccine

MedImmune announced today that the U.S. Department of Health and Human Services (HHS) has placed an order for an additional 29 million doses of its live attenuated influenza vaccine (LAIV) against the 2009 H1N1 influenza virus. This brings HHS orders to date to more than 40 million vaccine doses, with a total cumulative contract value of approximately $453 million.

22 Sep 2009

President Obama silent on the creation of a Global Fund for Education: Global AIDS Alliance

One year ago, on September 28, 2008, then-Candidate Barack Obama used the world stage provided by the annual meeting of the Clinton Global Initiative to promise that, if elected, he would work to create a Global Fund for Education.

22 Sep 2009

Results from a trial testing a 2009 H1N1 influenza vaccine in children look promising

Early results from a trial testing a 2009 H1N1 influenza vaccine in children look promising, according to the trial sponsor, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

22 Sep 2009

LSA's BCP in place to tackle demand for language assistance in the event of a potential swine flu pandemic

LSA (Language Services Associates), a leading provider of premium language-based solutions, today announced its comprehensive business continuity plan (BCP) for the 2009-2010 flu season. The strategy, which was devised by LSA’s BCP project management team, has been created to ensure the company is prepared for an increase in demand for language assistance in the event of a potential Swine Flu pandemic.

22 Sep 2009

U.N. report calls for $1.48B to help developing nations cope with H1N1

The U.N. this week will request that wealthy nations and development banks donate $1.48 billion to help developing countries fight H1N1 (swine flu), Bloomberg reports. "Most of the money is needed for vaccines and drugs … to help the least-developed nations cope with the influenza pandemic, according to a U.N. report obtained" Monday by the news service.

21 Sep 2009

Inhalable H1N1 vaccine to arrive in U.S. first week of October, CDC says

The Centers for Disease Control and Prevention on Friday announced it anticipates 3.4 million doses of inhalable H1N1 vaccines will be available by the first week of October - the initial influx of 195 million doses purchased by the U.S. government, CNN reports. The vaccine is approved for healthy people between the ages of two and 49, but not for pregnant women (9/18).

21 Sep 2009

U.S. Department of Health & Human Services requests BioCryst for proposal for peramivir supply

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that it has received a request for proposal (RFP) from the U.S. Department of Health & Human Services (HHS) for the supply of intravenous (i.v) peramivir for the treatment of critically ill influenza patients under Emergency Use Authorization (EUA).

21 Sep 2009

HHS awards $77.2 million contract to BioCryst to complete Phase 3 development of peramivir

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that it has been awarded a $77.2 million contract modification by the U.S. Department of Health & Human Services (HHS) to complete Phase 3 development of its influenza neuraminidase inhibitor, intravenous (i.v.) peramivir, for the treatment of complicated influenza.

21 Sep 2009

Flu Preparedness Program offering latest information on the H1N1 virus

TeleVox Software, Inc., a leading provider of communication solutions for the healthcare industry, today launched its Flu Preparedness Program (www.televox.com/fluprogram), designed to enable health care providers to give their patients the latest information about fighting the Flu and the H1N1 virus, commonly referred to as the swine flu. Doctors can easily communicate with their patients through a variety of methods such as voice, email, postcards and text messages.

21 Sep 2009

No communication to workers from employers about policies in the workplace pertaining to H1N1: Study

Most workers have not had any direction from their employers about the upcoming flu season, according to a national survey released today by Mansfield Communications Inc.

21 Sep 2009

ICTs play a major role in the health care sector

Today the GridTalk project launches its 8th GridBriefing at the Enabling Grids for E-sciencE (EGEE) conference in Barcelona. The report covers how information and communication technologies (ICTs), particularly computing grids, are used in the health and biomedical sectors of European research. EGEE has supported this research community since the project's birth and it is the second largest user group after physics research.

21 Sep 2009

Pandemic News and Research

Further Reading

Report outlining global weaknesses in preventing deadly diseases

Automated software solution for H1N1 preparation

Report on species-crossing microbes and H1N1

Noveko to provide antimicrobial face masks and respirators to Air Transat

Axion Health and CHS to deliver Workforce Emergency Preparedness and Response programs

Academy of Friends announces its 2009-2010 fundraising for 11 Bay Area HIV/AIDS service organizations

Chan calls for additional H1N1 vaccines for poor countries during WHO Asia-Pacific regional meeting

Sanofi Pasteur receives additional order H1N1 vaccine

Antigen to block infection by genetically-diverse strains of HIV

U.S. HHS orders for an additional 29 million doses of MedImmune's influenza vaccine

President Obama silent on the creation of a Global Fund for Education: Global AIDS Alliance

Results from a trial testing a 2009 H1N1 influenza vaccine in children look promising

LSA's BCP in place to tackle demand for language assistance in the event of a potential swine flu pandemic

U.N. report calls for $1.48B to help developing nations cope with H1N1

Inhalable H1N1 vaccine to arrive in U.S. first week of October, CDC says

U.S. Department of Health & Human Services requests BioCryst for proposal for peramivir supply

HHS awards $77.2 million contract to BioCryst to complete Phase 3 development of peramivir

Flu Preparedness Program offering latest information on the H1N1 virus

No communication to workers from employers about policies in the workplace pertaining to H1N1: Study

ICTs play a major role in the health care sector

Best practices - optimize qPCR processes for pathogen detection eBook

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News